Definitive Diagnostics: Funding, Investors & Team (Sep 2026)
The Definitive Diagnostics platform is able to detect the most common types of cancer, such as breast, lung, and colorectal, as well as more aggressive forms like pancreatic and ovarian cancer.
Definitive Diagnostics has raised $100k across 1 funding round on record, the most recent a Seed of $100k announced in May 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Definitive Diagnostics Company Profile and Key Stats
Latest funding round on record: May 2024.
Definitive Diagnostics Funding Rounds
Definitive Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Definitive Diagnostics Funding Compared to Other Biotechnology Startups
Definitive Diagnostics' latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Definitive Diagnostics in Biotechnology and New York
Companies Similar to Definitive Diagnostics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Definitive Diagnostics Funding FAQs
What does Definitive Diagnostics do?
The Definitive Diagnostics platform is able to detect the most common types of cancer, such as breast, lung, and colorectal, as well as more aggressive forms like pancreatic and ovarian cancer.
How much funding has Definitive Diagnostics raised?
Definitive Diagnostics has raised $100k across 1 round on record. The most recent is a Seed of $100k announced in May 2024.
When did Definitive Diagnostics last raise funding?
Definitive Diagnostics' most recent funding round on record is a Seed of $100k, announced in May 2024.
Who founded Definitive Diagnostics?
FundedIQ lists Ellis Malovany (Founder) at Definitive Diagnostics.
Where is Definitive Diagnostics headquartered?
Definitive Diagnostics is based in New York, United States.
How many employees does Definitive Diagnostics have?
Definitive Diagnostics is in the 1-10 employee band.
How does Definitive Diagnostics' funding compare to other Biotechnology startups?
Definitive Diagnostics' latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Definitive Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Definitive Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.